{
  "pmid": "29925695",
  "abstract": "A porcine model of neurofibromatosis type 1 that mimics the human disease.  White KA(1), Swier VJ(1), Cain JT(1), Kohlmeyer JL(2), Meyerholz DK(3), Tanas  MR(3), Uthoff J(4)(5), Hammond E(4)(5), Li H(6)(7), Rohret FA(8), Goeken A(3),  Chan CH(1), Leidinger MR(3), Umesalma S(9), Wallace MR(6)(7), Dodd RD(10)(11),  Panzer K(12), Tang AH(13), Darbro BW(11)(12), Moutal A(14), Cai S(14), Li W(14),  Bellampalli SS(14), Khanna R(14), Rogers CS(8), Sieren JC(4)(5)(11), Quelle  DE(2)(3)(9)(11), Weimer JM(1)(15).  Author information: (1)Pediatrics and Rare Diseases Group, Sanford Research, Sioux Falls, South  Dakota, USA. (2)Molecular Medicine Program. (3)Department of Pathology, and. (4)Department of Radiology, University of Iowa Carver College of Medicine, Iowa  City, Iowa, USA. (5)Department of Biomedical Engineering at the University of Iowa, Iowa City,  Iowa, USA. (6)Department of Molecular Genetics and Microbiology and. (7)University of Florida Health Cancer Center, University of Florida,  Gainesville, Florida, USA. (8)Exemplar Genetics, Coralville, Iowa, USA. (9)Department of Pharmacology and. (10)Department of Internal Medicine, University of Iowa Carver College of  Medicine, Iowa City, Iowa, USA. (11)Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa,  USA. (12)Department of Pediatrics, University of Iowa Carver College of Medicine,  Iowa City, Iowa, USA. (13)Department of Microbiology and Molecular Cell Biology, Leroy T. Canoles Jr.  Cancer Research Center, Eastern Virginia Medical School, Norfolk, Virginia. (14)Department of Pharmacology, University of Arizona, Tucson, Arizona, USA. (15)Department of Pediatrics, Sanford School of Medicine at the University of  South Dakota, Sioux Falls, South Dakota, USA.  Loss of the NF1 tumor suppressor gene causes the autosomal dominant condition,  neurofibromatosis type 1 (NF1). Children and adults with NF1 suffer from  pathologies including benign and malignant tumors to cognitive deficits,  seizures, growth abnormalities, and peripheral neuropathies. NF1 encodes  neurofibromin, a Ras-GTPase activating protein, and NF1 mutations result in  hyperactivated Ras signaling in patients. Existing NF1 mutant mice mimic  individual aspects of NF1, but none comprehensively models the disease. We  describe a potentially novel Yucatan miniswine model bearing a heterozygotic  mutation in NF1 (exon 42 deletion) orthologous to a mutation found in NF1  patients. NF1+/ex42del miniswine phenocopy the wide range of manifestations seen  in NF1 patients, including caf√© au lait spots, neurofibromas, axillary  freckling, and neurological defects in learning and memory. Molecular analyses  verified reduced neurofibromin expression in swine NF1+/ex42del fibroblasts, as  well as hyperactivation of Ras, as measured by increased expression of its  downstream effectors, phosphorylated ERK1/2, SIAH, and the checkpoint regulators  p53 and p21. Consistent with altered pain signaling in NF1, dysregulation of  calcium and sodium channels was observed in dorsal root ganglia expressing  mutant NF1. Thus, these NF1+/ex42del miniswine recapitulate the disease and  provide a unique, much-needed tool to advance the study and treatment of NF1.  DOI: 10.1172/jci.insight.120402 PMCID: PMC6124439 PMID: 29925695 [Indexed for MEDLINE]  Conflict of interest statement: Conflict of interest: The authors have declared  that no conflict of interest exists.",
  "methods": "",
  "introduction": "",
  "results": "",
  "discussion": "",
  "fetched_at": "2026-02-16T15:45:16.508336",
  "abstract_length": 3428,
  "methods_length": 0,
  "introduction_length": 0,
  "results_length": 0,
  "discussion_length": 0
}